Abstract
We evaluated blood pressure in a sample of patients with neurofibromatosis type 1 (NF1), using ambulatory blood pressure monitoring (ABPM), to determine whether ABPM, when compared with casual BP recordings, allowed the detection of a higher risk for hypertension. We also evaluated the correlation between BP and vascular abnormalities. We studied 69 NF1 patients (36 males and 33 females) with a mean age of 11±4 years, divided into group A, with 24-h mean systolic blood pressure (SBP) or diastolic blood pressure (DBP) <95th percentile, and group B, with mean SBP or DBP >95th percentile. Standard electrocardiography and M-mode, two-dimensional echocardiography were performed and all patients were in sinus rhythm. ABPM identified 11 hypertensive patients (16%); 5 had a mean SBP >95th percentile, 3 mean SBP−DBP >95th percentile, and 3 a mean DBP >95th percentile. Laboratory and other investigations to exclude secondary hypertension were normal. Cardiac abnormalities were found in 13 of the 69 patients (18.8%) with NF1. There were no significant clinical and cardiac differences between the normotensive and hypertensive group. Our data emphasize the importance of periodic ABPM in NF1 patients to diagnose hypertension early and avoid target organ damage and increased mortality.
Similar content being viewed by others
References
Riccardi VM (1981) Von Recklinghausen neurofibromatosis. N Engl J Med 27:1617–1627
Listernick R, Charrow J (1990) Neurofibromatosis type 1 in childhood. J Pediatr 16:845–851
Grifa A, Piemontese M, Meichionda R (1995) Screening of neurofibromatosis type 1 gene: identification of a large deletion and of an intronic variant. Clin Genet 47:281–284
Garicochea B, Giorgi R, Odone VF, Dorihiac-Llacer PE, Bendit I (1998) Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukaemia. Leuk Res 22:1003–1010
Riccardi VM (1992) Type 1 neurofibromatosis and the pediatric patient. Curr Probl Pediatr 22:66–106
Wallace MR, Marcbuk DA, Andersen LB (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181–186
Cawthon RM, Weiss M, Xu G, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O’Connell P (1990) A major segment of the neurofibromatosis type 1 gene: cDna sequence, genomic structure, and point mutations. Cell 62:193–201
Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type I locus. Cell 62:187–192
Norton KK, Xu J, Gutmann DH (1995) Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis 2:13–21
Lakkis MM, Epstein JA (1998) Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development 125:4359–4367
Kurien A, Jhon PR, Milford DV (1997) Hypertension secondary to progressive vascular neurofibromatosis. Arch Dis Child 76:454–455
Virdis R, Balestrazzi P, Zampolli M, Donadio A, Street M, Lorenzetti E (1994) Hypertension in children with neurofibromatosis. J Hum Hypertens 8:395–397
Hirayama K, Kobayashi M, Yamaguchi N, Iwabuchi S, Gotoh M, Inoue C, Yamada S, Ebata H, Ishida H, Koyama A (1996) A case of renovascular hypertension associated with neurofibromatosis. Nephron 72:699–704
Strauss S, Bistritzer T, Azizi E, Peer A, Morag B (1993) Renal artery stenosis secondary to neurofibromatosis in children: detection by Doppler ultrasound. Pediatr Nephrol 7:32–34
Gutherie GP Jr (1982) Hypertension and neurofibromatosis. Hypertension 4:894−897
Halpern M, Currarino G (1965) Vascular lesions causing hypertension in neurofibromatosis. N Engl J Med 273:248–252
Cappuccio FP, Allan R, Barron J, MacGregor GA, Murday VA (1999) Secondary hypertension and clinical genetics: usual presentation with unusual diagnosis. J Hum Hypertens 13:79–80
Weber MA (1988) Whole-day blood pressure. Hypertension 11:288–298
Bald M, Kubel S, Rascher W (1994) Validity and reliability of 24 h blood pressure monitoring in children and adolescents using a portable, oscillometric device. J Hum Hypertens 8:363–366
Baumgart P, Walger P, Gemen S, Von Eiff M, Raidt H, Rahn KH (1991) Blood pressure elevation during the night in chronic renal failure, hemodialisys and after renal transplantation. Nephron 57:293–298
Calzolari A, Giordano U, Matteucci MC, Pastore E, Turchetta A, Rizzoni, Alpert B (1988) Hypertension in young patients after renal transplantation: ambulatory blood pressure monitoring versus casual blood pressure. Am J Hypertens 11:497–501
Nishibata K, Nagashima M, Tsuji A, Hasegawa S, Nagai N, Goto M, Hayashi H (1995) Comparison of casual blood pressure and twenty-four-hour ambulatory blood pressure in high school students. J Pediatr 127:34–39
Lin AE, Birch PH, Korf BR, Tenconi R, Niimura M, Poyhonen M, Armfield Uhas K, Sigorini M, Virdis R, Romano C, Bonioli E, Wolkenstein P, Pivnick EK, Lawrence M, Friedman JM (2000) Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet 95:108–117
Stumpf DA, Alksne JF, Annegers JF, et al (1988) Neurofibromatosis Conference Statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578
Lama G, Grassia C, Avino G, Esposito Salsano M, Calabrese E, Tarallo MR, Riccio V, Cantone D, Conforti R, Costagliola C, Melone MRAB, Scuotto A (1998) La neurofibromatosi tipo 1 in età pediatrica: 10 anni di esperienza. Riv Ital Pediatr 24:99–107
Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263
Update on the 1987 Second Task Force Report on high blood pressure in children and adolescent: a working group report from the National High Blood Pressure Education Program (1996) Pediatrics 98:649–658
Lurbe E, Redon J, Liao Y, Tacons J, Cooper RS, Alvarez V (1994) Ambulatory blood pressure monitoring in normotensive children. J Hypertens 12:1417–1423
Mancia G, Sega R, Bravi C, Vito G de, Valagussa F, Cesana G, Zanchetti A (1995) Ambulatory blood pressure normality: results from the Pamela Study’s. J Hypertens 13:1377–1390
Beltman FW, Heesen WF, Smit AJ, Lie KI, Meyboom-de jong B (1996) Acceptance and side effects of ambulatory blood pressure monitoring: evaluation of new technology. J Hum Hypertens 10 [Suppl 3]:S39–S42
Chandar JJ, Sfakianakis GN, Zilleruelo GE, Guerra JJ, Georgiou MF, Abibtol CL, Montane BS, Strauss J (1999) ACE inhibition scintigraphy in the management of hypertension in children. Pediatr Nephrol 13:493–500
Devereux RB, Alonso DR, Lutas EM, Gottleib GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458
De Simone G, Daniels SR, Meyer RA, Roman MJ, De Divitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260
Alpert B, Daniels SR (1997) Twenty-four-hour ambulatory blood pressure monitoring: now that technology has come of age we need to catch up. J Pediatr 130:167–169
Tilford DL, Kelsh RC (1973) Renal artery stenosis in childhood neurofibromatosis. Am J Dis Child 126:665–668
Halpern M, Currarino G (1965) Vascular lesions causing hypertension in neurofibromatosis. N Engl J Med 273:248–252
Reubi F (1944) Les vaisseauex et les Glandes Endocrines dans la Neurofibromatose. Ztschr f Path u Bakt 7:168–236
Reubi F (1945) Neurofibromatose et Lesions Vasculaires. Schweiz Med Wochenschr 75:463–465
Green JF Jr, Fitzwater JE, Burgess J (1992) Arterial lesions associated with neurofibromatosis. Am J Clin Pathol 22:66–106
Salyer WR, Salyer DC (1974) The vascular lesions of neurofibromatosis. Angiology 25:510–519
Lehrnbecher T, Gassel AM, Rauh V, Kirchner T, Huppertz HI (1994) Neurofibromatosis presenting as a severe systemic vasculopathy. Eur J Pediatr 153:107–109
Tedesco MA, Di Salvo G, Ratti G, Natale F, Calabrese E, Grassia C, Iacono A, Lama G (2001) Arterial distensibility and ambulatory blood pressure monitoring in young patients with neurofibromatosis type 1. Am J Hypertens 14:559–566
Tedesco MA, Di Salvo G, Natale F, Pergola V, Calabrese E, Grassia C, Ratti G, Iarussi D, Iacono A, Calabrò R, Lama G (2002) The heart in neurofibromatosis type 1: an echocardiographic study. Am Heart J 143:883–888
Zoller M, Rembeck B, Akesson HO, Angervall L (1995) Life exepectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden. Acta Derm Venereol (Stockh) 75:136–140
Friedman JM, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, Lin AE, McManus B, Korf BR (2002) Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. Genet Med 4:105–111
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lama, G., Graziano, L., Calabrese, E. et al. Blood pressure and cardiovascular involvement in children with neurofibromatosis type1. Pediatr Nephrol 19, 413–418 (2004). https://doi.org/10.1007/s00467-003-1397-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-003-1397-5